Ipamorelin

Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) classified as a growth-hormone secretagogue and a member of the broader growth-hormone releasing peptide (GHRP) family. It is characterized by its high selectivity as a ligand at the growth-hormone secretagogue receptor (GHS-R), a property that has made it a widely referenced tool compound in mechanistic studies of somatotropic signaling. Supplied by Pet & Peps Research as a lyophilized powder at >=99% HPLC purity, it is intended exclusively as a laboratory reference material for in-vitro and non-clinical companion-animal research models.

Within the companion-animal research context, Ipamorelin is studied primarily in relation to growth-hormone releasing pathways and the regulation of the somatotropic axis. Investigators use it as a selective probe to interrogate GHS-R-mediated signaling in cellular assays and controlled study models relevant to canine and feline physiology, where its receptor selectivity provides a defined experimental input for pathway characterization. Its role as a secretagogue makes it of research interest in efforts to map endocrine signaling cascades and receptor behavior under laboratory conditions.

Ipamorelin is additionally investigated within recovery and healthy-aging research frameworks, where scientists explore secretagogue-associated signaling as it relates to age-correlated physiological processes in companion-animal study models. All such work is conducted strictly at the laboratory and mechanistic level. This material carries no therapeutic positioning: it is not intended to diagnose, treat, cure, or prevent any condition, and it is not for human or veterinary use.